Colombia Pemetrexed Market Size & Outlook, 2025-2033


Colombia Pemetrexed Market Insights

  • According to Reed Intelligence analysis, the Colombia Pemetrexed Market size was USD 9.44 Million in 2024 and is projected to reach USD 10.6 Million by 2033.
  • The Colombia market is projected to grow at a CAGR of 1.28% between 2026 and 2033.
  • By segment, Malignant Pleural Mesothelioma emerged as the largest By Application in terms of market size in 2024.
  • Malignant Pleural Mesothelioma is anticipated to remain the most attractive By Application segment, recording the fastest growth during the forecast period.

Other Key Findings


  • As of 2024, Colombia held 0.4% of the global Pemetrexed Market size.
  • By 2033, United States is anticipated to capture the largest share of the global Pemetrexed Market.
  • In LATAM, Brazil is expected to lead the regional Pemetrexed Market size by 2033.
  • Chile will remain the fastest-growing market in LATAM, reaching USD 11.17 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 9.44 Million
Market Size In 2033 USD 10.6 Million
Largest segment Malignant Pleural Mesothelioma
Units Revenue in USD Million
CAGR 1.28% (2025-2033)
Segmnetation Covered
By Application
  1. Malignant Pleural Mesothelioma
  2. Non-Squamous NSCLC
By End-User
  1. Hospitals
  2. Oncology Centers
  3. Online Pharmacies
  4. Offline Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends